INRange Systems Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:INRange Systems Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6480
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
INRange Systems Inc (INRange) is a medical device company that develops and markets medication delivery systems. The company offers EMMA, a remote medication management system that provides individual unit dose control of medication dispensing, which is managed through a web-based scheduling system remotely controlled and programmed by the pharmacist. It also provides E-Kit, a solution that provides individual unit dose control of narcotics and inventory control of non-narcotics; EMMA Narcotic E-Kit, designed to provide individual unit dose control; EMMA E-Cabinet, a solution designed to increase on-hand storage of control and non-control medications; and narcotics control solution that allows long term care pharmacies to package and dispense medications for patients. The company caters to pharmacies, independent or assisted living, managed care, and skilled nursing facilities. INRange is headquartered in Altoona, Pennsylvania, the US.

INRange Systems Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
INRange Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
INRange Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
INRange Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
INRange Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
INRange Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
INRange Systems Inc, Medical Equipment, Deal Details 10
Venture Financing 10
INRange Systems Raises Funds through Venture Financing 10
INRange Systems Raises Additional USD0.3 Million in Venture Financing 11
INRange Systems Raises USD0.4 Million in Venture Financing 12
INRange Systems Inc – Key Competitors 13
INRange Systems Inc – Key Employees 14
INRange Systems Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
INRange Systems Inc, Medical Equipment, Key Facts 2
INRange Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
INRange Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
INRange Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
INRange Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
INRange Systems Inc, Deals By Market, 2012 to YTD 2018 8
INRange Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
INRange Systems Raises Funds through Venture Financing 10
INRange Systems Raises Additional USD0.3 Million in Venture Financing 11
INRange Systems Raises USD0.4 Million in Venture Financing 12
INRange Systems Inc, Key Competitors 13
INRange Systems Inc, Key Employees 14

List of Figures
INRange Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
INRange Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
INRange Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
INRange Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
INRange Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
INRange Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
INRange Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
INRange Systems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[INRange Systems Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Methode Electronics Inc (MEI):企業の財務・戦略的SWOT分析
    Summary Methode Electronics Inc (Methode) is technology company. The company offers products such as user interface, lighting, sensors, medical devices, power distribution and digital data. Its user interface products include, guages, cameras, bell pushers, industrial remote controls, touch panels, …
  • Astronics Corp:企業の戦略・SWOT・財務情報
    Astronics Corp - Strategy, SWOT and Corporate Finance Report Summary Astronics Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Norfolk Southern Corp (NSC):企業の財務・戦略的SWOT分析
    Norfolk Southern Corp (NSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Marriott Vacations Worldwide Corp:企業の戦略・SWOT・財務分析
    Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report Summary Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • AGL Energy Ltd (AGL):電力:M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Aster DM Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Aster DM Healthcare (Aster DM), formerly Dr Moopens Healthcare Management Services LLC is a healthcare service provider that provides patient care services. The company offers services such as cardiac surgery, mobile medical units, village adoption, early cancer detection centers and dialysi …
  • Jiangsu Jiuding New Material Co Ltd (002201):企業の財務・戦略的SWOT分析
    Jiangsu Jiuding New Material Co Ltd (002201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • China Taiping Insurance Holdings Company Limited:戦略・SWOT・企業財務分析
    China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • T7 Global Berhad (T7GLOBAL):石油・ガス:M&Aディール及び事業提携情報
    Summary T7 Global Berhad (T7 Global), formerly Tanjung Offshore Berhad, is an oil and gas company that offers gas generators and integrated services. The company's services include topside maintenance, engineering and procurement, installation and commissioning, initial engineering design layout, pr …
  • S.C. Hidroelectrica SA:企業の戦略的SWOT分析
    S.C. Hidroelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Terramin Australia Ltd:企業の戦略・SWOT・財務情報
    Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Phio Pharmaceuticals Corp (RXII):企業の財務・戦略的SWOT分析
    Summary Phio Pharmaceuticals Corp (Phio Pharmaceuticals), formerly known as RXi Pharmaceuticals Corp, is a biotechnology company. It discovers, develops and commercializes immuno-oncology therapeutics based RNAi platform to treat cancer. Its product pipeline includes PH-762, PH-894 and PH-804 for ad …
  • Consun Pharmaceutical Group Ltd (1681):製薬・医療:M&Aディール及び事業提携情報
    Summary Consun Pharmaceutical Group Ltd (Consun Pharmaceutical) is a pharmaceutical company that manufactures and distributes Chinese medicines. The company offers gadopentetate injection, cetirizine hydrochloride oral solution, iron dextran oral solution, uremic granules, compound amino acid inject …
  • Bridgestone Corporation:企業の戦略・SWOT・財務分析
    Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • IntegraGen SA (ALINT):製薬・医療:M&Aディール及び事業提携情報
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • iBio Inc (IBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Harmonic Inc (HLIT):企業の財務・戦略的SWOT分析
    Harmonic Inc (HLIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Versantis AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Versantis AG (Versantis) is a pharmaceutical company that develops new generation of medicines and diagnostics for treating patients with liver diseases. The company’s pipeline product includes VS-01, a liposomal-based peritoneal dialysis fluid that acts as a clearance enhancer for a large s …
  • Mitsui E&S Holdings Co., Ltd:企業の戦略・SWOT・財務分析
    Mitsui E&S Holdings Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui E&S Holdings Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bradken Pty Ltd:企業の戦略・SWOT・財務分析
    Bradken Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Bradken Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆